Brand Profile

An Australian Innovative Medical Device Company and manufacturer of the revolutionary HypoMon™. AIMEDICS’ purpose is to help people with insulin dependent diabetes detect and prevent overnight hypoglycaemia. 

Service Provided

UNLOCKE™ research – competitor, market, etc. | Market position | Marketing strategy | Launch planning & ongoing counsel
[Successfully launching HypoMon™ into the global medical supply & hospital markets.]

“The feedback we have received from our launch market in Europe indicates that the LOCKE pty ltd team have provided us with exactly the right approach, positioning and materials to positively impact this market in an ethical and profitable manner.” 

Sean Gray

Chief Commercialisation Office, AIMEDICS PTY LTD